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background:  Supply-demand type 2 myocardial infarction (T2MI) is frequently encountered. Little is known about gender differences 
in patients with T2MI in contrast to type 1 MI (T1MI) and non-MI troponin (cTn) increases. We sought to compare mortality according to 
gender among these groups.
methods:  Retrospective study of 1245 patients presenting to the ED in which serial cTnI (OCD VITROS ES assay; 99th URL: 0.034 μg/L) 
were measured on clinical indication. Characteristics and outcomes including in-hospital and 180-day mortality were compared according 
to gender among T1MI, T2MI and non-MI cTnI increases.
Results:  374 (240 men, 134 women) patients had at least one increased cTnI. 77 (6.2%) had T1MI, 255 (20.5%) T2MI, and 42 (3.4%) no 
MI with an increased cTnI. Mean maximum values within 24-h of admission according to men and women respectively were: 34.1 vs. 20.9 
μg/L (p=0.4) in T1MI, 1.8 vs. 1.2 μg/L (p=0.5) in T2MI and 0.6 vs. 0.4 μg/L (p=0.3) in no MI with an increased cTnI. In-hospital mortality 
and post-discharge mortality in men was 5% and 9% in T1MI, 9% and 17% in T2MI, 12% and 16% in non-MI cTnI increases, and 2% and 
5% in no MI with normal cTnI; whereas in women it was 0% (both) for T1MI, 14% and 25% for T2MI, 6% (both) for non-MI cTnI increases, 
and 1% and 4% for no MI with normal cTnI. Women with T2MI had a significantly worse post-discharge mortality in contrast to women with 
T1MI (25% vs. 0%, p=0.03; RR:11.1 CI:0.7-175).
conclusion:  Women with T2MI have significantly worse outcomes in comparison to women with T1MI\
.
